Publication Date:
2015-12-04
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Ghani, Azra C -- Burgess, Deborah Hay -- Reynolds, Alison -- Rousseau, Christine -- England -- Nature. 2015 Dec 3;528(7580):S50-2. doi: 10.1038/nature16038.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, Norfolk Place, London W2 1PG, UK. ; Principal, Kimataifa Diagnostics and Devices Consulting, 17319 15th Drive SE, Mill Creek, Washington 98012. Seattle, USA. ; Bill and Melinda Gates Foundation, 500 5th Avenue North, Seattle, Washington 98109, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/26633765" target="_blank"〉PubMed〈/a〉
Keywords:
Communicable Diseases/*diagnosis/*economics/virology
;
Cost-Benefit Analysis
;
Diagnostic Tests, Routine/*economics/utilization
;
Global Health/*economics
;
HIV Infections/diagnosis/virology
;
Health Resources/economics
;
Hemorrhagic Fever, Ebola/diagnosis/epidemiology
;
Humans
;
Leishmaniasis, Visceral/diagnosis
;
Sensitivity and Specificity
;
Viral Load
Print ISSN:
0028-0836
Electronic ISSN:
1476-4687
Topics:
Biology
,
Chemistry and Pharmacology
,
Medicine
,
Natural Sciences in General
,
Physics
